CN Stock MarketDetailed Quotes

688166 Brightgene Bio-Medical Technology Co.,Ltd.

Watchlist
  • 34.48
  • -0.15-0.43%
Market Closed Jun 7 15:00 CST
14.57BMarket Cap74.47P/E (TTM)

Brightgene Bio-Medical Technology Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
31.53%248.37M
34.00%1.05B
Operating revenue
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
31.53%248.37M
34.00%1.05B
Total operating cost
16.64%267.34M
25.15%980.32M
23.89%699.6M
20.45%462.93M
26.32%229.2M
-0.78%783.33M
4.30%564.69M
8.62%384.34M
35.63%181.44M
31.93%789.49M
Operating cost
16.19%145.69M
38.56%521.41M
30.85%378.94M
35.70%258.34M
38.61%125.39M
-18.32%376.3M
-8.19%289.61M
-8.71%190.38M
4.67%90.47M
30.14%460.67M
Operating tax surcharges
12.95%1.58M
9.35%5.71M
33.21%4.42M
68.82%2.87M
142.25%1.39M
23.66%5.22M
17.70%3.32M
-11.92%1.7M
-58.52%575.8K
76.06%4.22M
Operating expense
-10.54%14.81M
-8.60%64.07M
-25.16%45.1M
-38.65%28.42M
0.40%16.56M
63.74%70.09M
168.00%60.27M
194.12%46.32M
189.38%16.49M
146.28%42.81M
Administration expense
0.93%28.54M
1.31%116.4M
7.71%83.11M
4.45%51.81M
21.43%28.28M
11.81%114.89M
5.33%77.16M
11.56%49.6M
12.62%23.29M
29.95%102.75M
Financial expense
30.84%11.67M
146.34%24.14M
613.79%24.21M
625.93%18.11M
13.16%8.92M
70.73%9.8M
-161.77%-4.71M
-34.50%2.49M
409.85%7.88M
21.80%5.74M
-Interest expense (Financial expense)
30.15%13.91M
87.36%44.42M
214.91%33.57M
202.32%23.94M
9.58%10.69M
144.54%23.71M
22.10%10.66M
60.50%7.92M
359.48%9.76M
374.64%9.7M
-Interest Income (Financial expense)
48.52%-1.54M
-703.62%-17.99M
-707.35%-10.4M
-985.37%-7.45M
-126.80%-2.99M
-146.09%-2.24M
-87.32%-1.29M
-37.59%-686.02K
-682.66%-1.32M
90.38%-909.73K
Research and development
33.68%65.05M
20.08%248.59M
17.81%163.82M
10.16%103.39M
13.85%48.66M
19.47%207.02M
16.09%139.05M
18.29%93.85M
93.19%42.74M
23.04%173.29M
Credit Impairment Loss
-49.71%125.75K
-279.70%-2.47M
-146.30%-6.88M
18.84%-3.78M
119.38%250.04K
113.33%1.37M
60.32%-2.79M
31.54%-4.66M
-317.36%-1.29M
-1,133.10%-10.3M
Asset Impairment Loss
----
-46.70%-21.49M
-13.46%-8.11M
-13.46%-8.11M
----
-55.91%-14.65M
-1,549.30%-7.15M
-2,142.32%-7.15M
----
-0.01%-9.4M
Other net revenue
Fair value change income
-840.99%-2.48M
84.68%-520.01K
109.73%255.43K
-50.95%1.74M
228.34%334.71K
-529.84%-3.39M
-20,533.24%-2.62M
1,031.75%3.55M
-1,799.84%-260.8K
1,679.37%789.75K
Invest income
-192.83%-4.55M
-472.54%-14.74M
-189.46%-8.24M
-146.38%-4.81M
-144.26%-1.55M
-57.14%3.96M
305.80%9.21M
516.90%10.36M
-271.98%-635.56K
160.26%9.23M
-Including: Investment income associates
-135.05%-3.41M
-52.58%-13.61M
-63.55%-7.5M
-49.21%-4.65M
---1.45M
3.46%-8.92M
29.55%-4.58M
18.56%-3.11M
----
-311.85%-9.24M
Asset deal income
----
----
----
----
----
57.00%9.89K
--0
----
----
--6.3K
Other revenue
472.38%4.8M
45.12%30.27M
-28.85%5.65M
45.61%3.95M
54.25%838.63K
263.52%20.86M
76.64%7.95M
-36.19%2.71M
10.43%543.67K
-47.33%5.74M
Operating profit
-6.50%70.69M
-21.44%190.24M
-6.72%197.96M
-6.03%113.54M
15.80%75.61M
-6.50%242.16M
6.34%212.21M
1.06%120.83M
18.64%65.29M
34.15%258.99M
Add:Non operating Income
358,861.36%6.32K
-81.06%199.02K
-81.93%194.61K
-98.67%11.37K
-99.99%1.76
882.79%1.05M
1,953.19%1.08M
2,471.72%854.31K
31.00%27.27K
-48.13%106.94K
Less:Non operating expense
--111.08K
67.50%1.67M
-41.68%462.78K
-37.76%278.41K
----
-39.20%999.01K
-49.66%793.53K
-70.67%447.32K
-97.14%15.1K
-15.74%1.64M
Total profit
-6.64%70.59M
-22.06%188.77M
-6.97%197.69M
-6.57%113.28M
15.78%75.61M
-5.92%242.21M
7.30%212.5M
2.68%121.24M
19.77%65.3M
34.57%257.46M
Less:Income tax cost
-8.20%8.78M
-50.14%15.35M
-39.49%20.95M
-13.13%14.89M
27.50%9.56M
54.70%30.78M
26.98%34.62M
16.22%17.14M
26.52%7.5M
-9.39%19.9M
Net profit
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
18.95%57.8M
40.27%237.56M
Net profit from continuing operation
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
18.95%57.8M
40.27%237.56M
Less:Minority Profit
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
-27,242.61%-2.95M
-1,128.24%-6.39M
Net profit of parent company owners
-9.47%64.07M
-15.51%202.47M
-2.95%191.79M
-2.29%109.44M
16.48%70.77M
-1.77%239.62M
11.73%197.62M
4.80%112M
25.00%60.75M
43.60%243.95M
Earning per share
Basic earning per share
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
25.00%0.15
46.34%0.6
Diluted earning per share
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
25.00%0.15
46.34%0.6
Other composite income
-2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
94.16%-1.03M
Other composite income of parent company owners
---2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
----
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
----
94.16%-1.03M
Total composite income
-9.87%59.52M
-17.04%147.02M
-3.51%171.83M
-10.17%94.33M
14.26%66.04M
-25.07%177.22M
4.36%178.09M
2.33%105.01M
20.06%57.8M
55.83%236.53M
Total composite income of parent company owners
-12.70%61.78M
-14.29%176.07M
-5.54%186.88M
-6.66%105.38M
16.48%70.77M
-15.44%205.42M
11.93%197.84M
6.36%112.9M
26.17%60.75M
59.49%242.93M
Total composite income of minority owners
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
-27,242.61%-2.95M
-1,128.24%-6.39M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M31.53%248.37M34.00%1.05B
Operating revenue 11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M31.53%248.37M34.00%1.05B
Total operating cost 16.64%267.34M25.15%980.32M23.89%699.6M20.45%462.93M26.32%229.2M-0.78%783.33M4.30%564.69M8.62%384.34M35.63%181.44M31.93%789.49M
Operating cost 16.19%145.69M38.56%521.41M30.85%378.94M35.70%258.34M38.61%125.39M-18.32%376.3M-8.19%289.61M-8.71%190.38M4.67%90.47M30.14%460.67M
Operating tax surcharges 12.95%1.58M9.35%5.71M33.21%4.42M68.82%2.87M142.25%1.39M23.66%5.22M17.70%3.32M-11.92%1.7M-58.52%575.8K76.06%4.22M
Operating expense -10.54%14.81M-8.60%64.07M-25.16%45.1M-38.65%28.42M0.40%16.56M63.74%70.09M168.00%60.27M194.12%46.32M189.38%16.49M146.28%42.81M
Administration expense 0.93%28.54M1.31%116.4M7.71%83.11M4.45%51.81M21.43%28.28M11.81%114.89M5.33%77.16M11.56%49.6M12.62%23.29M29.95%102.75M
Financial expense 30.84%11.67M146.34%24.14M613.79%24.21M625.93%18.11M13.16%8.92M70.73%9.8M-161.77%-4.71M-34.50%2.49M409.85%7.88M21.80%5.74M
-Interest expense (Financial expense) 30.15%13.91M87.36%44.42M214.91%33.57M202.32%23.94M9.58%10.69M144.54%23.71M22.10%10.66M60.50%7.92M359.48%9.76M374.64%9.7M
-Interest Income (Financial expense) 48.52%-1.54M-703.62%-17.99M-707.35%-10.4M-985.37%-7.45M-126.80%-2.99M-146.09%-2.24M-87.32%-1.29M-37.59%-686.02K-682.66%-1.32M90.38%-909.73K
Research and development 33.68%65.05M20.08%248.59M17.81%163.82M10.16%103.39M13.85%48.66M19.47%207.02M16.09%139.05M18.29%93.85M93.19%42.74M23.04%173.29M
Credit Impairment Loss -49.71%125.75K-279.70%-2.47M-146.30%-6.88M18.84%-3.78M119.38%250.04K113.33%1.37M60.32%-2.79M31.54%-4.66M-317.36%-1.29M-1,133.10%-10.3M
Asset Impairment Loss -----46.70%-21.49M-13.46%-8.11M-13.46%-8.11M-----55.91%-14.65M-1,549.30%-7.15M-2,142.32%-7.15M-----0.01%-9.4M
Other net revenue
Fair value change income -840.99%-2.48M84.68%-520.01K109.73%255.43K-50.95%1.74M228.34%334.71K-529.84%-3.39M-20,533.24%-2.62M1,031.75%3.55M-1,799.84%-260.8K1,679.37%789.75K
Invest income -192.83%-4.55M-472.54%-14.74M-189.46%-8.24M-146.38%-4.81M-144.26%-1.55M-57.14%3.96M305.80%9.21M516.90%10.36M-271.98%-635.56K160.26%9.23M
-Including: Investment income associates -135.05%-3.41M-52.58%-13.61M-63.55%-7.5M-49.21%-4.65M---1.45M3.46%-8.92M29.55%-4.58M18.56%-3.11M-----311.85%-9.24M
Asset deal income --------------------57.00%9.89K--0----------6.3K
Other revenue 472.38%4.8M45.12%30.27M-28.85%5.65M45.61%3.95M54.25%838.63K263.52%20.86M76.64%7.95M-36.19%2.71M10.43%543.67K-47.33%5.74M
Operating profit -6.50%70.69M-21.44%190.24M-6.72%197.96M-6.03%113.54M15.80%75.61M-6.50%242.16M6.34%212.21M1.06%120.83M18.64%65.29M34.15%258.99M
Add:Non operating Income 358,861.36%6.32K-81.06%199.02K-81.93%194.61K-98.67%11.37K-99.99%1.76882.79%1.05M1,953.19%1.08M2,471.72%854.31K31.00%27.27K-48.13%106.94K
Less:Non operating expense --111.08K67.50%1.67M-41.68%462.78K-37.76%278.41K-----39.20%999.01K-49.66%793.53K-70.67%447.32K-97.14%15.1K-15.74%1.64M
Total profit -6.64%70.59M-22.06%188.77M-6.97%197.69M-6.57%113.28M15.78%75.61M-5.92%242.21M7.30%212.5M2.68%121.24M19.77%65.3M34.57%257.46M
Less:Income tax cost -8.20%8.78M-50.14%15.35M-39.49%20.95M-13.13%14.89M27.50%9.56M54.70%30.78M26.98%34.62M16.22%17.14M26.52%7.5M-9.39%19.9M
Net profit -6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M18.95%57.8M40.27%237.56M
Net profit from continuing operation -6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M18.95%57.8M40.27%237.56M
Less:Minority Profit 52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M-27,242.61%-2.95M-1,128.24%-6.39M
Net profit of parent company owners -9.47%64.07M-15.51%202.47M-2.95%191.79M-2.29%109.44M16.48%70.77M-1.77%239.62M11.73%197.62M4.80%112M25.00%60.75M43.60%243.95M
Earning per share
Basic earning per share -11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.2725.00%0.1546.34%0.6
Diluted earning per share -11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.2725.00%0.1546.34%0.6
Other composite income -2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-3,236.33%-34.2M270.05%211.75K227.26%903.5K94.16%-1.03M
Other composite income of parent company owners ---2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-----3,236.33%-34.2M270.05%211.75K227.26%903.5K----94.16%-1.03M
Total composite income -9.87%59.52M-17.04%147.02M-3.51%171.83M-10.17%94.33M14.26%66.04M-25.07%177.22M4.36%178.09M2.33%105.01M20.06%57.8M55.83%236.53M
Total composite income of parent company owners -12.70%61.78M-14.29%176.07M-5.54%186.88M-6.66%105.38M16.48%70.77M-15.44%205.42M11.93%197.84M6.36%112.9M26.17%60.75M59.49%242.93M
Total composite income of minority owners 52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M-27,242.61%-2.95M-1,128.24%-6.39M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg